Here’s whether Sabra Healthcare REIT, Inc. (SBRA) is worth buying in 2026 —
based on weekly-updated price trend, RSI momentum, and return vs.
the S&P 500. Our current read: Bullish.
🟢
Bullish
Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+0.39% over 10 days); RSI 56 — healthy momentum range; strong 1-year return of +21.2%. Currently 2.6% off its 52-week high. Score: +6/7.
SBRA is in a confirmed uptrend, trading above both its 50-day ($20.33) and 200-day ($19.32) moving averages. An RSI of 55.6 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of +21.2% compares to +27.9% for SPY (trailed the market by 6.6%).
$10,000 invested 1 year ago→ $12,124 today
vs. S&P 500 (SPY) — same period trailed market by 6.6%
1-Year Price Chart
Daily candles
MA-50MA-200UpDown
Signal Check
✓Above 200-day MA ($19.32)
✓Above 50-day MA ($20.33)
✓RSI(14) neutral zone (30–70) — currently 55.6
✓Positive return (+21.2%)
✓Within 10% of period high (−2.6%)
Period Range $20.72
$17.08$21.28
RSI (14) 55.6
0 · OversoldOverbought · 100
Key Metrics
Price$20.72
Period Return+21.2%
Period High$21.28
Period Low$17.08
Drawdown−2.6%
MA-50$20.33
MA-200$19.32
RSI (14)55.6
Avg Volume (30d)2.1M
vs. SPYtrailed by 6.6%
Return Rank#557 of 1236
Trend Signals
Price is above the 200-day moving average ($19.32)